ZYNTEGLO is manufactured and delivered through a highly coordinated and regulated process that involves close collaboration with the referring physician, the ZYNTEGLO Qualified Treatment Centre, and bluebird bio.

Qualified Treatment Centres Have Been Carefully Assessed for:

• Mission alignment with gene therapy
• Optimised patient access
• Clinical care capabilities
• Gene therapy manufacturing

Please continue to check back for updates as Qualified Treatment Centres are added.